Excellent answer.
Unfortunately a lot of their competition is pulling a Gnome3 and messing up their sites. Moniker is imploding as we speak, and Namecheap added enough Javascript-for-Javascript's-sake to give Godaddy a wet dream. Incremental development was supposed to generate highly-usable sites because common sense was supposed to be injected by the consumer of the site along the way. But it seems like the exact opposite has happened. "Hot messes" are everywhere.
I honestly think the employment pool for web developers has been deluged by hipsters over the last few years. Where have all the down-to-earth pros gone?
Nope. At the end I specifically said EV. Which for MSFT was cut in half over the period, unlike ORCL which is back to almost the same as the bubble peak. Its direct competitor Apple ate Microsoft's lunch during that period and AAPL's EV shows that fact clearly.
And needless to say, comparing MSFT to pets.com makes no sense, nor does lumping "tech" in one big basket.
Bottom line is they had a monopoly and a golden opportunity to leverage it into the same thing that Apple did. They sat around and tried to protect the empire instead of innovating. That's what the valuation shows in black and white.
Given the dotcom bubble I thought it would be unfair too. But if you look at just large cap tech, it's nowhere near as bad as what happened to the pure-play dotcoms and networkers:
Over the same time frame:
Oracle: $86B -> $185B
Apple: $18B -> $547B
HP: $45B -> $64B
And of course IPOs that happened a couple years later like Google and Salesforce were multi-baggers.
So comparing the peak mkt cap of the bubble is actually not that unfair. Considering Microsoft had a monopoly in 2000 and couldn't even maintain a constant enterprise value over 14 years, again, I wouldn't call that a "wildly successful" performance by the CEO.
Like it or not, CEOs are measured by their share price. When Ballmer took over in first quarter of 2000, Microsoft's market cap was $534.42B.
http://www.wikinvest.com/stock...
Their current market cap is $399B.
$135B in market cap was lost over 14 years while he was CEO. You may be right that he's a great marketing guy, etc., but "wildly successful" as a CEO may be a touch unrealistic.
Whether a drug actually works is immune to politics and bureaucracy because it's a scientific and statistical issue (which assumes professional trial design and execution).
Whether a drug is approved certainly considers politics. See the travesty surrounding commissioner Margaret Hamburg and Eteplirsen for the treatment of Duchenne's muscular dystrophy. It's gut-wrenching. So you're right in a sense, just a little harsh imho.
But I think you may be misunderstanding how drug development works and why it drags out so long (i.e. when you said "get her some stem cells"). It's because it's really tough to make something that works. The FDA is responsible for approving trial design, considering input from advisory committees and give final marketing approval to drugs. They do not do the R&D, design trials or conduct any phases of the trial, that's up to the individual biotech and pharmaceutical companies to perform and pay for. It takes a lot of time and money for both sides to come to an agreement that something is safe and effective enough to be injected into a human being.
So the "pioneering medical research" you're referring to is basically 1) consult a specialist to see what drugs/therapies have been accepted as beneficial, 2) there may be some drugs in phase 2 or 3 that have been given accelerated approval or compassionate use status by the FDA or 3) see what's available on clinicaltrials.gov and hope there's one she qualifies for. Very broad but this is the general idea of how it works; going outside of these paths is a recipe for disappointment.
Lastly, your point about finding support groups is really good, it's a way to short-circuit the process and see what others have done.
I'm not either and don't know the answer, maybe the actual neuroscientist that responded earlier can. My main point was that only controlled trials will answer that question. The charlatans specifically target folks like the submitter that are in a dire situation looking for hope. Warnings like I posted above from the FDA help separate the pseudo from real science and results. Thought it was worth mentioning for those who only know the term at a cursory level.
Worth modding up. For years the term "stem cell therapy" has attracted a bunch of charlatans promising cures way beyond what's currently feasible (or realistically possible). The FDA weighed in again recently: http://www.fda.gov/forconsumer...
Having said that, companies like Neuralstem are conducting actual research into regenerative medicine with clinical trials but it remains to be seen how this will work out. And there is serious medical research into cancer stem cells (CD47, etc.) that is an extension of immunotherapy using monoclonal antibodies.
So it's important to be specific. Traveling to Mexico so you can have some "stem cells" implanted in your spine and expect a magical cure...not a great idea.
Given how many folks have gently pointed out the numerous factual, logical and common sense errors in your previous slashdot posts...I wouldn't be too hasty in casting stones.
In other words, regulation?
We gave you an atomic bomb, what do you want, mermaids? -- I. I. Rabi to the Atomic Energy Commission